Malvern-based Endo Health Solutions has been ordered to pay over $1.5 billion in criminal financial penalties after the ...

Endo used to manufacture and sell a long-acting opioid painkiller called Opana ER, which was withdrawn in 2017 after the U.S. FDA said its benefit did not outweigh public health risks associated ...

Endo Pharmaceuticals has announced it will remove its Opana ER opioid painkiller from the US market, a month after the FDA requested because of the potential for abuse. Dublin-based Endo said that ...

Endo International is the latest drugmaker to ... it of wrongdoing in its marketing and promotion of painkiller Opana ER (oxymorphone), which was withdrawn from the market five years ago, as ...

The proposed sale comes nearly a year after Endo emerged from bankruptcy protection. Endo Inc. said Tuesday it has entered into an agreement to divest its international pharmaceuticals business to ...

MALVERN, Pa., March 11, 2025 /CNW/ -- Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced it has entered into a definitive agreement to divest its International Pharmaceuticals ...